LXRX
LEXICON PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$2.05
+0.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 52.15x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.23x
- Price / sales
- 22.00x
- Price / cash flow
- -11.44x
Enterprise value
- Enterprise value
- $780.8M
- EV / sales
- 18.83x
- EV / EBITDA
- -14.94x
- EV / EBIT
- -14.33x
- Market cap
- $912.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026